IntelliPharmaCeutics International (IPCI) announced after the bell Monday that the FDA has granted final approval of the Company's dexmethylphenidate hydrochloride extended-release capsules for the 15 and 30 mg strengths.
IntelliPharmaCeutics International gapped open dramatically higher Tuesday and is now up 1.78 at $3.67 on the highest volume of the year. The stock has surged to a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.